Skip to main content
. 2022 Oct 9;14(10):694. doi: 10.3390/toxins14100694

Table 3.

EAR rate of each antivenom and severity grading of EARs.

Types of AV Used (Quantity Given) Frequency of AV Administration EAR Rate
(%)
Grading of EARs, N (%)
Total Doses Given
N (%)
No. of Doses That Incurred EARs (N) Mild Moderate Severe
Hematotoxic AV:
   GPV (3860 vials) 341 (29.5) 39 11.4 14 (4.1) 24 (7.0) 1 (0.3)
   MPV (3071 vials) 283 (24.5) 63 22.3 24 (8.5) 24 (8.5) 15 (5.3)
   RV (1019 vials) 68 (5.9) 2 2.9 0 (0) 0 (0) 2 (2.9)
   HPAV (1516 vials) 146 (12.6) 22 15.1 7 (4.8) 10 (6.8) 5 (3.4)
   Total (9466 vials) 838 (72.5) 126 15.0 45 (5.4) 58 (6.9) 23 (2.7)
Neurotoxic AV:
   Cobra (2754 vials) 213 (18.4) 31 14.6 17 (8.0) 11 (5.2) 3 (1.4)
   MK (400 vials) 26 (2.2) 3 11.5 2 (7.7) 1 (3.8) 0 (0)
   KC (164 vials) 7 (0.6) 1 14.3 0 (0) 0 (0) 1 (14.3)
   NPAV (888 vials) 73 (6.3) 12 16.4 6 (8.2) 3 (4.1) 3 (4.1)
   Total (4206 vials) 319 (27.5) 47 14.7 25 (7.8) 15 (4.7) 7 (2.2)
Overall Total
(13,672 vials)
1157 (100) 173 15.0 70 (6.1) 73 (6.3) 30 (2.6)

AV; antivenom(s), EARs; early adverse reactions, N; number of doses of AV, GPV; green pit viper, MPV; Malayan pit viper, RV; Russell’s viper, HPAV; hemato polyvalent antivenom, MK; Malayan krait, KC; king cobra, NPAV; neuro polyvalent antivenom.